1. Bijnsdorp IV, Peters GJ (2008) Hollow fiber assay. In: Schwab M (ed). Encyclopedia of Cancer. Springer Verlag: Berlin, Germany, pp 1404–1406.
2. Bonezzi K, Taraboletti G, Borsotti P, Bellina F, Rossi R, Giavazzi R (2009) Vascular disrupting activity of tubulin-binding 1,5-diaryl-1H-imidazoles. J Med Chem 52: 7906–7910.
3. Boven E, Winograd B, Berger DP, Dumont MP, Braakhuis BJ, Fodstad O, Langdon S, Fiebig HH (1992) Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res 52: 5940–5947.
4. Boyd MR (1992) The future of new drug development. In: Niederhuber JE (ed). Current Therapy in Oncology. B.C. Decker Inc: Philadelphia, PA, USA, pp 11–22.
5. Bradshaw TD (2010) Phortress: the smart antitumour agent which induces its own metabolism. Pharm J 284: 23–24.